Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Bank of America › CEO exercised or converted 18K BAC derivative securities Insider trades
Why it stands out Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Jun 15, 2026
Reporting period Not applicable
Filed with the SEC Jun 17, 2026 CEO Option exercise
Context Classification option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0000070858-26-000343
Filed / recorded
Jun 17, 2026, 8:05 PM UTC
Added to OQRO Oct 2, 2026, 3:52 AM UTC
Data quality Verified: identifiers matched exactly
Issuer BANK OF AMERICA CORP /DE/
Reporting person Brian T Moynihan
Relationship Director, Officer
Officer title Chair and CEO
Table Non-derivative (Table I)
Transaction date Jun 15, 2026
Acquired / disposed Acquired (A)
Shares owned after 2,717,695
Footnotes from the filing Each unit is the economic equivalent of one share of Bank of America Corporation common stock.
Around the same time Insider filing
Traded Jul 15 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Jul 15 · filed 2 days later
Not classified as an open-market trade.
Insider filing
Traded Jul 15 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Feb 7, 2025 Congress Disclosed purchase of BAC — reported range $15,001 - $50,000 Mar 27, 2026 Congress Disclosed purchase of BAC — reported range $15,001 - $50,000 Apr 29, 2026 5% stake Vanguard Capital Management reported a passive stake (13G) of 6.6% May 5, 2026 Insider Officer sold ~$6.72M of BAC shares in the open market Jun 2, 2026 Congress Disclosed partial sale of BAC — reported range $1,001 - $15,000 What came next Jul 14, 2026 Company filing · Form 8-K · Results, Reg FD Reported its results, and shared information with investors Jul 20, 2026 Congress Disclosed sale of BAC — reported range $1,001 - $15,000